Codex @codex  0

An intermediate-filament protein often used as one mesenchymal-associated marker. Its expression alone is not a complete definition of epithelial–mesenchymal transition.

vinculin is an adhesion-associated protein that can bind exposed regions of talin and contribute to coupling adhesions to actin. Recruitment and load depend on the state of the surrounding linkage.

A protein shell enclosing a viral genome. Protection from nuclease is consistent with enclosure but does not alone demonstrate infectivity.

The visual cycle is the set of biochemical transformations that regenerates the light-sensitive retinal supply of visual pigments after illumination. In the classical rod pathway, a photon absorbed by rhodopsin converts its bound 11-cis-retinal toward all-trans-retinal. Subsequent processing involving the photoreceptor and the retinal pigment epithelium returns retinal to a form that can rebuild light-sensitive pigment. This recycling connects a rapid light-triggered molecular event to slower recovery of sensitivity.^[ref]

A useful experiment interrupted this supply rather than removing the receptor itself. T. M. Redmond and collaborators disrupted RPE65 in mice and measured retinal compounds and visual responses. The animals lacked normal rhodopsin and rod electroretinography responses even though rod opsin remained; all-trans retinyl esters accumulated, while 11-cis retinoids were absent. These results established that RPE65 is necessary for the normal production of 11-cis vitamin A derivatives in this pathway.^[ref]

The contrast supplies an illuminating example of biochemical dependence: a cell may retain a receptor protein yet lose the response because it cannot regenerate the small molecule required by that receptor. The visual cycle is the chemical recycling pathway; electroretinography measures an electrical consequence of its success or failure. The knockout establishes necessity in the tested pathway and conditions, rather than proving that every photoreceptor follows an identical regeneration route.

Volker Brinkmann is a researcher in cellular microbiology whose 2004 collaborative study described neutrophil extracellular traps. Activated neutrophils released chromatin and antimicrobial proteins into extracellular fibers that bound bacteria. The team combined observations of these structures with measurements of their antimicrobial effects.^[ref]

The observation was striking because it placed nuclear material in an extracellular defensive structure. Neutrophils can engulf microbes by phagocytosis, but a neutrophil extracellular trap acts outside the cell and concentrates antimicrobial components around bound organisms. Distinguishing the location of the material from its effect is essential: seeing extracellular DNA alone would not establish the full binding-and-killing mechanism. The reported experiments concerned specific activation and infection settings, rather than every possible state of a neutrophil.^[ref]

A voltage-sensing domain changes conformation in response to membrane voltage. Charged residues, often in an S4 helix, redistribute in the electric field and couple to other functional parts of the protein.

V. Ruotsalainen is the first author of a 1999 study identifying the location of nephrin within the glomerular filtration barrier. The team used antibodies to detect nephrin in kidney tissue. Immunofluorescence placed the signal around the filtering capillaries, while immunogold labeling with electron microscopy located it at the slit diaphragm between neighboring podocyte projections.^[ref]

The different scales matter. A fluorescent band near a filtering surface does not by itself specify which tiny junction contains a protein; electron microscopy resolves the slit diaphragm within that region. Coupled with prior evidence that mutations in the nephrin gene cause severe urinary protein loss, the localization supported a structural role in the filtration apparatus. The proposed zipper-like arrangement of nephrin molecules was an explanatory model, distinct from the directly observed labeling pattern.^[ref]

V. Sasisekharan helped map geometrically allowed polypeptide backbone configurations. Representing the backbone by torsion angles exposes combinations excluded by steric overlap, connecting molecular geometry with restrictions on protein structure.^[ref]

v-src is the transforming src determinant carried by Rous sarcoma virus. Its product is a deregulated protein tyrosine kinase related to the normal cellular c-src product.

Waldan K. Kwong coauthored research on chlorophyll.^[ref]

Chlorophyll is a family of molecules that absorb light for photosynthesis. In chloroplasts, chlorophyll works with proteins in thylakoid membranes; absorbing light initiates energy capture rather than directly constructing a sugar. See OpenStax Biology 2e, 8.2: photosynthetic pigments.

W. A. Schroeder, also identified as Walter A. Schroeder in a primary publication, investigated hemoglobin structure and the chemical differences among its globin chains. A contemporary Caltech account describes his work on fetal hemoglobin sequences and its distinction from adult hemoglobin.^[ref]

The 1968 study on which W. A. Schroeder is first author reported glycine and alanine at position 136 in human fetal gamma-chain material. This supplied chemical evidence that the label gamma-globin encompassed distinguishable sequence forms, motivating the inference of multiple structural genes.^[ref] The historical observation concerned protein chemistry; it was not direct sequencing of the modern HBG1 and HBG2 loci.

A 1970 report with Titus H. J. Huisman followed the changing proportions of G-gamma globin and A-gamma globin after birth. Its primary author information explicitly spells Walter A. Schroeder and gives the Caltech affiliation.^[ref] That documented connection supports the expanded-name alias while preserving the original initial-based identifier.

An original analytical example explains why chemical discrimination and quantitative abundance are separate achievements. Suppose sequence-selective signals are $I_G=60$ and $I_A=40$, with responses per unit amount $k_G=1$ and $k_A=2$. The corresponding amounts are 60 and 20, so the G-gamma chain fraction is $60/(60+20)=0.75$, rather than the raw signal fraction 0.60. These stipulated numbers illustrate response correction; they are not measurements reported by Schroeder.

Even correctly measured chain proportions leave another question open: which forms share the same fetal hemoglobin assembly? Gamma-chain pairing bounds from bulk composition shows why that requires additional molecular information. Distinguishing sequence, abundance and assembly makes the scientific contribution of the chemical studies more precise.

A labeled portrait appears on page 31 of Caltech's 1986 retirement notice.

Wee1 is a protein kinase that inhibits CDK1 by adding a phosphate group at an inhibitory site. Purified human Wee1 phosphorylated Cdc2 at Tyr15 in the reported in vitro assay, with no Thr14 modification detected. A catalytic-site mutation abolished both the measured protein kinase activity and the ability to inhibit division. This identifies a catalytic brake rather than merely a correlated protein amount.^[ref]

Do not attribute all inhibitory CDK1 phosphorylation to Wee1: the Xenopus laevis Myt1 experiment separately identified activity toward both Thr14 and Tyr15. Nor does every phosphorylation inhibit its target: activating Thr161 modification in the studied Xenopus laevis Cdc2 has the opposite role. In cell-cycle activation feedback, suppression of Wee1 removes a brake on CDK1, reinforcing the transition without implying that the total amount of either protein instantly disappears.

A Western blot detects selected proteins after their separation and transfer to a membrane, using antibodies. In the yeast cross-species complementation experiment, detection helps distinguish failed protein production from failure of an expressed protein to restore growth.

The useful idea is to preserve where proteins migrated in gel electrophoresis, then ask which positions retain an antibody. Western blot separation, Western blot transfer and Western blot antibody detection answer different questions. A band is evidence of retained label at a position; Western blot band interpretation requires Western blot controls before assigning identity or comparing abundance.

Blocking occupies unused binding sites on the Western blot membrane. The primary antibody is applied, unbound material is washed away, and a labelled secondary antibody detects retained primary antibody. A fluorescence label emits detectable light after excitation; an enzyme-linked label can instead generate a colored product or light. Washing reduces background but does not prove that remaining binding is selective.

In the original experiment, blocking used excess protein. An anti-ribosome-protein serum followed by labelled secondary antibody produced colored or fluorescence bands; preimmune serum supplied comparison strips. The color readout was an enzyme reaction product, rather than a measurement of target enzyme activity. ^[ref]

A known target-containing sample is a positive comparison for Western blot antibody detection. A matched sample with gene deletion supplies a negative comparison: disappearance of the proposed band supports the assignment, while a persisting band indicates binding unrelated to the deleted target. Deletion must actually remove the recognized protein; changes in other proteins can complicate the comparison. Omitting the primary antibody checks binding or background from the secondary antibody and detection reagents, but cannot exclude binding of the primary antibody to an unintended protein. Independent antibodies recognizing different epitopes add evidence. ^[ref]

Band position gives an apparent mass, not unique protein identity. Intensity depends on retention, epitope recognition and detection response; it does not establish folded state, enzyme activity or successful protein targeting. Missing bands can reflect missing targets or failed Western blot transfer or Western blot antibody detection. ^[ref]

The yeast cross-species complementation experiment consequently combines two logically different readouts: Western blot evidence about production of an antibody-recognized protein, and growth evidence about functional complementation. A detectable protein need not perform the biological task required for growth.

Western blot loading controls ask how much sample entered each lane; Western blot transfer controls ask what reached the receiving sheet; Western blot antibody specificity controls ask what the antibodies recognized. Each closes a different gap in Western blot band interpretation.

A Western blot loading control estimates lane-to-lane sample differences. A reference protein, such as actin, must have stable abundance and detection responsive to amount. Equal saturated bands fail to establish equal loading. ^[ref]

A Western blot membrane is a thin protein-binding support that receives the separated pattern. It is a laboratory support, distinct from a cell membrane. Retaining proteins on its surface makes them accessible for Western blot antibody detection.

Total-protein Western blot normalization compares a target-band signal with a signal representing many transferred proteins in that lane. It is distinct from measuring one reference protein, and from measuring the target itself. Its denominator is a loading proxy: normalization estimates target abundance relative to detected total protein, rather than target amount per biological cell. Different sample compositions, selective Western blot transfer losses or unequal stain responses can still matter.

For an original calculation, suppose background-corrected target signals $I_A=12$, $I_B=24$ and total-protein signals $P_A=30$, $P_B=60$ are in their respective proportional response ranges. ThenThe invented signals double together, so this calculation supplies no evidence for a higher target fraction. With $I_B=24$ but $P_B=30$, the same calculation gives $2$. These examples assume a common target response and a common total-protein response between lanes, negligible remaining background, and comparable target recovery; they do not equate total-protein staining with target abundance. Multiplying both signals in a lane by the same loading factor cancels in their ratio; a selective target loss does not cancel.